Last checked at 
* FTSE 100 down 0.2 pct, mining shares top losers
* Shire falls on declined drug approval
* Barclays rises on media report (Adds detail)
By Kit Rees
LONDON, Oct 19 (Reuters) - Britain's top share index slippedon Monday as mining stocks suffered after China reported itseconomic growth had slowed, while drugmaker Shire dipped afterU.S. regulators withheld approval for a new drug.
Britain's FTSE 100 index was down 0.4 percent at6,352.97 points at 1425 GMT, underperforming European indexes.
Mining shares fell along with metals prices after Chinareported that economic growth slowed in the third quarter. Thedata were slightly better than expected, but growth was still atits weakest since 2009, reflecting a sluggish global economythat is hurting demand for metals.
Anglo American fell 6.5 percent. Glencore,Antofagasta and BHP Billiton were all down 2.4to 4.4 percent.
Analysts also cited Chinese manufacturing data, which camein weaker than forecast.
"I suspect that, given the relatively poor performance ofmanufacturing, that is probably a reason why mining stockshave taken a little bit of a dent," said Laith Khalaf, senioranalyst at Hargreaves Lansdown.
Despite a rally of around 5 percent so far in October, theFTSE 100 remains down about 10 percent from record highs reachedin April, amid growing concern over China's economy.
Pharmaceutical company Shire turned positive inafternoon trade. The stock had fallen after the U.S. Food andDrug Administration declined to approve its dry-eye drug,lifitegrast, and requested an additional clinical study.
Shire's chief executive said that the company continued toplan for a potential 2016 launch of the drug.
"We believe the CRL (Complete Response Letter) was fairlywell anticipated by the market, with Shire having been warningof the risk of a delay, pending more clinical data for the lastfew months," analysts at JPMorgan wrote in a note.
Barclays rose 1 percent after a report in theFinancial Times that the company will speed up the reduction insize of its investment bank. (Editing by Larry King)
